IE31885B1 - Reduction of corticosteroid side effects - Google Patents

Reduction of corticosteroid side effects

Info

Publication number
IE31885B1
IE31885B1 IE93/68A IE9368A IE31885B1 IE 31885 B1 IE31885 B1 IE 31885B1 IE 93/68 A IE93/68 A IE 93/68A IE 9368 A IE9368 A IE 9368A IE 31885 B1 IE31885 B1 IE 31885B1
Authority
IE
Ireland
Prior art keywords
corticosteroid
side effects
compositions
pyridyl
cortisone
Prior art date
Application number
IE93/68A
Other versions
IE31885L (en
Original Assignee
Unimed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unimed Inc filed Critical Unimed Inc
Publication of IE31885L publication Critical patent/IE31885L/en
Publication of IE31885B1 publication Critical patent/IE31885B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

1,175,482. Corticosteroid compositions. UNIMED Inc. 15 Jan., 1968 [9 March, 1967], No. 2078/68. Heading A5B. Corticosteroid compositions with reduced corticosteroid side effects comprise a corticosteroid and at least one compound selected from beta-(2- or 4- pyridyl) alkyl alkylamines and dialkylamines; 1-(2<SP>1</SP>- or 41-pyridyl)-2, 3- cis- or trans-dicarboxylic acid cyclobutanes; alphapicolinic acid dialkylamides; and non- toxic acid addition salts thereof. Examples of anti-inflammatory corticosteroids include cortisone, cortisone phosphate, hydrocortisone and the acetate and 21-sodium succinate thereof, prednisone, dexamethasone and the sodium phosphate salt thereof, ACTH, corticosterone, 11-dehydrocorticosterone, 11-desoxycorticosterone and aldosterone. Suitable salts include the hydrochloride, sulphate, tartrate, fumarate and gluconate. The compositions may be administered orally, parenterally or topically in the form of tablets, ampoules, drops, suspensions or ointments. Corticosteroid side effects are reduced by administering to a non-human animal simultaneously with, before or after administration of the corticosteroid at least one of the above-mentioned compounds. [GB1175482A]
IE93/68A 1967-03-09 1968-01-23 Reduction of corticosteroid side effects IE31885B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62179167A 1967-03-09 1967-03-09

Publications (2)

Publication Number Publication Date
IE31885L IE31885L (en) 1968-09-09
IE31885B1 true IE31885B1 (en) 1973-02-07

Family

ID=24491653

Family Applications (1)

Application Number Title Priority Date Filing Date
IE93/68A IE31885B1 (en) 1967-03-09 1968-01-23 Reduction of corticosteroid side effects

Country Status (9)

Country Link
US (1) US3474168A (en)
BE (1) BE710504A (en)
DE (1) DE1667925A1 (en)
FR (1) FR7356M (en)
GB (1) GB1175482A (en)
IE (1) IE31885B1 (en)
IL (1) IL29319A (en)
NL (1) NL6801136A (en)
SE (1) SE347874B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4353896A (en) * 1981-06-08 1982-10-12 Levy Michael A Penetrating topical medicament
US5358943A (en) * 1987-12-29 1994-10-25 Clark Abbot F Use of tetrahydrocortisol to prevent elevations in intraocular pressure caused by corticosteroids
US4945089A (en) * 1987-12-29 1990-07-31 Alcon Laboratories, Inc. Use of tetrahydrocortexolone to prevent elevations in intraocular pressure caused by corticosteroids
US20060074063A1 (en) * 1995-12-29 2006-04-06 Fernandez-Pol Jose A Pharmacological agent and method of treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2794763A (en) * 1955-01-27 1957-06-04 Pfizer & Co C Pressor amines
US3105010A (en) * 1959-06-19 1963-09-24 Schering Corp Steroid-amino acid compositions for preventing negative nitrogen balance
US3415833A (en) * 1964-04-16 1968-12-10 Unimed Inc Pyridyl-dicarboxylic acid cyclobutane derivatives
US3984304A (en) * 1974-11-11 1976-10-05 Ppg Industries, Inc. Electrode unit

Also Published As

Publication number Publication date
DE1667925A1 (en) 1971-07-22
IL29319A (en) 1971-11-29
GB1175482A (en) 1969-12-23
US3474168A (en) 1969-10-21
FR7356M (en) 1969-10-20
SE347874B (en) 1972-08-21
NL6801136A (en) 1968-09-10
BE710504A (en) 1968-06-17
IE31885L (en) 1968-09-09

Similar Documents

Publication Publication Date Title
EP0310541B1 (en) Antigestagenic and antioestrogenic compounds for the introduction of labour and interruption of pregnancy, as well as for the treatment of gynecologic disorders
CH661517A5 (en) AQUEOUS SOLUTIONS OF WATER-SOLUBLE INCLUDING COMPLEXES AND METHOD FOR THEIR PRODUCTION.
EP0772441A1 (en) Use of a progesterone antagonist and of a gestagen for the treatment of endometriosis or leiomyomata uteri
IE31885B1 (en) Reduction of corticosteroid side effects
DE60018707T2 (en) ANTI-ANDROGENES AND METHOD FOR THE TREATMENT OF DISEASES
DE2643936A1 (en) MEDICINAL PRODUCTS WITH ERYTHROPOIETIC EFFECTIVENESS
Derelanko et al. Effect of corticosteroids on indomethacin-induced intestinal ulceration in the rat
US2970944A (en) Parenteral solutions of steroid phosphates stabilized with creatinines
Howell et al. Effect of hypophysectomy on electrolyte excretion in dogs with ascites produced by thoracic inferior vena cava constriction
DE2431694A1 (en) Sequential, two-stage contraceptive agents - contg a gestagen in the first stage, a gestagen plus oestrogen in the second stage and opt complementary placeboss
DE2705002A1 (en) THERAPEUTIC PREPARATION
GB1174880A (en) Derivatives of alpha-Piperazinophenylacetonitrile and process for manufacture of same
US3657435A (en) 17beta-hydroxy - 17 - ethynyl-4-androsteno(3 2-c) -2&#39;-(p-fluorophenyl)pyrazole and compositions containing same
DE2539824A1 (en) PHARMACEUTICAL PREPARATION
GB1204809A (en) Novel quinoline derivatives, the preparation thereof and compositions containing the same
DE2348197C3 (en) Norethisteron-O-alkyloxime, process for their preparation and their use
DE3805064A1 (en) PHARMACEUTICAL PREPARATIONS FOR INITIATING BIRTH, FOR PREGNANCY AND FOR USE AS A CONCEPT
Hall et al. The availability of DL-threonine and DL-allothreonine for the formation of carbohydrate
DE2164988C3 (en) 2,2-Diphenylcyclopropanecarboxylic acid ester derivatives, processes for their preparation and pharmaceuticals containing them
DE2146239A1 (en) New contraceptive means
AT281277B (en) Process for the manufacture of pharmaceutical preparations
Swingle et al. Effect of Crystalline Suspensions of Adrenal Steroids Upon Life-Span of Adrenalectomized Dogs
GB1245155A (en) NOVEL 5-SUBSTITUTED-gamma-CARBOLINE DERIVATIVES AND THE SALTS THEREOF
DE4139114C2 (en) Use of monoesters from glucocorticoids and organic acids for the delayed treatment of diseases treatable with glucocorticoids in human medicine
DE1767898A1 (en) Process for the production of a pharmaceutical preparation